COVID-19: Shortage Of Monkeys May Slow Down Vaccine Development - Research
A shortage in the supply of monkeys may slow down the development of COVID-19 vaccines that are still in the early stages of development in the United States. This scarcity could be a major obstacle to the vaccine moving to the next stage. The scarcity of the primates in the country was revealed by The Atlantic magazine on Monday, August, 31. Scientists in the United States are particularly worried, with around 35,000 monkeys used in experiments there every year.